All the information you need about PHARMEXENCE to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-05-11 | Partially confidential | 2021-12-31 | Complete |
| 2021-04-08 | Partially confidential | 2020-12-31 | Complete |
| 2020-06-24 | Partially confidential | 2019-12-31 | Complete |
| 2019-07-18 | Partially confidential | 2018-12-31 | Complete |
| 2018-02-19 | Public | 2017-12-31 | Complete |
| 2017-03-24 | Public | 2016-12-31 | Complete |
| Name | PHARMEXENCE |
| Siren | 530160035 |
| Closing | 2018-12-31 |
| Registry code | 0401 |
| Registration number | 2040 |
| Management number | 2018B00334 |
| Activity code | 4775Z |
| Closing date n-1 | 2017-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2019-07-18 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Partially confidential |
| Address | 84480 LACOSTE |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AF Concessions, Patents and Similar Rights | 8 770.00 | 6 896.00 | 1 873.00 | 8 770.00 |
AT Other tangible assets | 2 010.00 | 498.00 | 1 512.00 | 2 010.00 |
BJ TOTAL (I) | 10 780.00 | 7 394.00 | 3 386.00 | 10 780.00 |
BL Raw materials, supplies | 12 524.00 | 12 524.00 | 12 524.00 | |
BT Goods | 31 414.00 | 31 414.00 | 31 414.00 | |
BZ Other receivables | 98 428.00 | 98 428.00 | 98 428.00 | |
CF Cash and cash equivalents | 244 098.00 | 244 098.00 | 244 098.00 | |
CH Prepaid expenses | 5 010.00 | 5 010.00 | 5 010.00 | |
CJ TOTAL (II) | 391 475.00 | 391 475.00 | 391 475.00 | |
CO Grand total (0 to V) | 402 256.00 | 7 394.00 | 394 862.00 | 402 256.00 |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 30 000.00 | 30 000.00 | 30 000.00 | |
DD Legal reserve (1) | 3 000.00 | 3 000.00 | 3 000.00 | |
DG Other reserves | 35 508.00 | 30 802.00 | 35 508.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 259 197.00 | 382 705.00 | 259 197.00 | |
DL TOTAL (I) | 327 706.00 | 446 508.00 | 327 706.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 4 066.00 | 565.00 | 4 066.00 | |
DX Trade payables and related accounts | 25 501.00 | 33 496.00 | 25 501.00 | |
DY Tax and social security liabilities | 36 409.00 | 67 841.00 | 36 409.00 | |
EA Other liabilities | 1 178.00 | 1 178.00 | ||
EC TOTAL (IV) | 67 156.00 | 101 903.00 | 67 156.00 | |
EE Grand total (I to V) | 394 862.00 | 548 411.00 | 394 862.00 | |
EI Including equity loans | 4 066.00 | 4 066.00 | ||
